Cleared Traditional

K201399 - HOPKINS ICG/NIR 10mm Ridgid Endoscope (...

K201399 is the FDA 510(k) clearance for HOPKINS ICG/NIR 10mm Ridgid Endoscope (... by KARL STORZ Endoscopy-America, Inc.. It is a Class 2 General & Plastic Surgery device (product code OWN) cleared through the Traditional 510(k) pathway after a 81-day FDA review.

K201399 · KARL STORZ Endoscopy-America, Inc. · General & Plastic Surgery device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 2020
Decision
81d
Days
Class 2
Risk

K201399 is an FDA 510(k) clearance for the HOPKINS ICG/NIR 10mm Ridgid Endoscope (modified) 0°, 30°, 45°, HOPKIN ICG/NIR.... Classified as Confocal Optical Imaging (product code OWN), Class II - Special Controls.

Submitted by KARL STORZ Endoscopy-America, Inc. (El Segundo, US). The FDA issued a Cleared decision on August 17, 2020 after a review of 81 days - a notably fast clearance cycle.

This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 876.1500 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all KARL STORZ Endoscopy-America, Inc. devices

Submission Details

510(k) Number K201399 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 28, 2020
Decision Date August 17, 2020
Days to Decision 81 days
Submission Type Traditional
Review Panel General & Plastic Surgery (SU)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 115d · This submission: 81d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code OWN Confocal Optical Imaging
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 876.1500
Definition Collection Of Light Signals For Visualization Of Cellular Microstructures.
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General & Plastic Surgery devices follow this clearance model.

Regulatory Peers - OWN Confocal Optical Imaging

All 42
Devices cleared under the same product code (OWN) and FDA review panel - the closest regulatory comparables to K201399.
ActivSight Intraoperative Imaging System
K203550 · Activ Surgical, Inc. · Apr 2021
KARL STORZ ICG Imaging System
K202925 · KARL STORZ Endoscopy-America, Inc. · Dec 2020
SPY-PHI System with SPY-PHI Fluorescence Assessment Software
K202244 · Novadaq Technologies Ulc. (Now A Part of Stryker) · Nov 2020
Visera Elite II Xenon Light Source, Telescope IR/Telescope Ultra, Visera Elite II Video System Center, HD 3CMOS Autoclavable Camera Head, HD 3CMOS Camera Head
K200542 · Olympus Medical Systems Corp. · Jul 2020
SPY Portable Handheld Imaging (SPY-PHI) System
K200737 · Novadaq Technologies Ulc. (Now A Part of Stryker) · May 2020
Cellvizio I.V.E. with Confocal Miniprobes
K193416 · Mauna Kea Technologies · Feb 2020